[Adherence to long-term medication: the particular case of the adjuvant endocrine therapy for breast cancer].
The aim of adjuvant hormone therapy for breast cancer is to reach, in daily practice, an efficacy similar to that obtained in clinical trials. In spite of the demonstrated efficacy of hormone therapy, compliance represents a major challenge and a multidimensional problem. A better understanding of the reasons underlying non-compliance would help identify the patients at higher risk and would permit the implementation of strategies to improve compliance to adjuvant hormone therapy. With this in mind, we undertook a review of the recent literature on the topic (Pub Med 2003-2009).
Bleret
V
V
Service de Sénologie, CHU de Liège, Belgique.
Collignon
J
J
Coucke
Ph
P
Cusumano
P
P
Desreux
J
J
Herman
Ph
P
Jerusalem
G
G
Maweja
S
S
Remacle
N
N
Rorive
A
A
Lifrange
E
E
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D055118:Medication Adherence; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal